ORCID
0009-0000-6866-3431 (Seward)
Document Type
Article
Publication Date
2026
DOI
10.25251/f6p8w4jh
Publication Title
Dermatology Online Journal
Volume
32
Issue
4
Pages
1-2
Abstract
This case report highlights recurrent cutaneous lichen planus as a rare adverse effect of ocrelizumab, with flares occurring after each infusion and improving with prophylactic prednisone. Recognizing this association may help clinicians diagnose and manage similar cases while allowing patients to continue an otherwise effective therapy.
Rights
© 2026 Avery Seward, Jeffrey P. Callen MD, & John D. Strickley MD
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Original Publication Citation
Seward, A., Callen, J., & Strickley, J. (2026). Drug-induced lichen planus associated with ocrelizumab. Dermatology Online Journal, 32(4), 1-2. https://doi.org/10.25251/f6p8w4jh
Repository Citation
Seward, A., Callen, J., & Strickley, J. (2026). Drug-induced lichen planus associated with ocrelizumab. Dermatology Online Journal, 32(4), 1-2. https://doi.org/10.25251/f6p8w4jh
Comments
The DOI to this article, https://doi.org/10.25251/f6p8w4jh, is non-functional.